EUVIMEDEUVIMED entdecken
Crossref

Evidence-Based Management of Urinary Tract Infections: Balancing Efficacy, Safety, and Antimicrobial Stewardship

Fadilullahi Opeyemi Ibiyemi, Deborah Awoniran, Anthony Godswill Imolele, Ismail Kolawole Odetayo, Lawal Fatimah Ayomide

International Journal of Research in Pharmacy and Allied Science · 2025

DOI: 10.71431/ijrpas.2025.41003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Research in Pharmacy and Allied Science, 2025. Verfasst von Fadilullahi Opeyemi Ibiyemi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections (UTIs) are some of the most prevalent infectious diseases around the globe, affecting about 150 million people every year and putting a considerable strain on healthcare systems, both financially and clinically. This comprehensive review takes a closer look at the current landscape of UTI treatment, shining a light on first-line antimicrobial agents like nitrofurantoin, trimethoprim-sulfamethoxazole, and fosfomycin, as well as alternative options such as fluoroquinolones, beta-lactams, aminoglycosides, and carbapenems. The review dives into how these treatments function, their effectiveness, and the emerging patterns of resistance, particularly the growing concern of antimicrobial resistance in common uropathogens, especially Escherichia coli. While there are established guidelines recommending specific first-line therapies, a noticeable gap remains between the evidence and what actually occurs in clinical practice, with fluoroquinolones like ciprofloxacin often being overprescribed for uncomplicated infections. The rising presence of multidrug-resistant organisms, such as extended-spectrum beta-lactamase-producing Enterobacterales, necessitates a careful reassessment of treatment strategies and a commitment to antimicrobial stewardship. With resistance rates exceeding 50% in certain regions for commonly used antibiotics, there's an urgent need for innovative treatment strategies, enhanced surveillance systems, and responsible antibiotic use to preserve the effectiveness of current therapies and address the escalating threat of antimicrobial resistance in managing UTIs.

Zitieren

APA

Ibiyemi, F. O., Awoniran, D., Imolele, A. G., Odetayo, I. K., & Ayomide, L. F. (2025). Evidence-Based Management of Urinary Tract Infections: Balancing Efficacy, Safety, and Antimicrobial Stewardship. International Journal of Research in Pharmacy and Allied Science. https://doi.org/10.71431/ijrpas.2025.41003

Vancouver

Ibiyemi FO, Awoniran D, Imolele AG, Odetayo IK, Ayomide LF. Evidence-Based Management of Urinary Tract Infections: Balancing Efficacy, Safety, and Antimicrobial Stewardship. International Journal of Research in Pharmacy and Allied Science. 2025. doi:10.71431/ijrpas.2025.41003

BibTeX
@article{Ibiyemi2025,
  author = {Ibiyemi, Fadilullahi Opeyemi and Awoniran, Deborah and Imolele, Anthony Godswill and Odetayo, Ismail Kolawole and Ayomide, Lawal Fatimah},
  title = {Evidence-Based Management of Urinary Tract Infections: Balancing Efficacy, Safety, and Antimicrobial Stewardship},
  journal = {International Journal of Research in Pharmacy and Allied Science},
  year = {2025},
  doi = {10.71431/ijrpas.2025.41003}
}
Kostenlos starten →